Back to search

Article

Neoantigen Load as a Prognostic and Predictive Marker for Stage II/III Non-Small Cell Lung Cancer in Chinese Patients

2020-12-21

Abstract excerpt

<h4>Background: </h4> Prognosis of stage II/III non–small-cell lung cancer (NSCLC) is unsatisfactory even after complete tumor resection and adjuvant chemotherapy. Tumors with high immunogenicity were defined as “hot tumors” and associated with clinical benefits from immunotherapy. Here we assessed the prognostic and predictive value of immunogenomic signatures and gene mutation characters for stage II/III non-sma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
aa235f43-fc45-5612-9b8e-3942946a9878
DOI
10.21203/rs.3.rs-130886/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Neoantigen Load as a Prognostic and Predictive Marker for Stage II/III Non-Small Cell Lung Cancer&nbsp;in Chinese PatientsDOI 10.21203/rs.3.rs-130886/v1
Neoantigen-Based Immunotherapy in Lung Cancer: Advances, Challenges and ProspectsSemantic proximity
An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy.Semantic proximity
Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer.Semantic proximity
Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer.Semantic proximity
Molecular Profiling reveals Tumor Immune Microenvironment Heterogeneity of Concurrent Lung Adenocarcinoma and Squamous Cell Carcinoma in Multiple Primary Lung CancersSemantic proximity
Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non-Small Cell Lung Cancer: Brief Report.Semantic proximity
The Current Lung Cancer Neoantigen Landscape and Implications for Therapy.Semantic proximity
ImmuniT Platform for Improved Neoantigen Prediction in Lung CancerSemantic proximity
Genomic and TCR Repertoire Intratumor Heterogeneity of Small-cell Lung Cancer and its Impact on SurvivalSemantic proximity
In silico neoantigen screening and HLA multimer-based validation identify immunogenic neopeptide in multifocal lung adenocarcinoma.Semantic proximity
Comparison of the somatic genomic landscape between central- and peripheral-type non-small cell lung cancer.Semantic proximity
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung CancerSemantic proximity
Select a neighboring publication to make it the new centre.